|
0
|
|
Antiretroviral Activity, Pharmacokinetics, and Safety of MK-8527, an Oral Nucleoside Reverse Transcriptase Translocation Inhibitor, in Adults With HIV-1 Who Had Not Previously Taken Antiretroviral Agents: Results From 2 Open-Label, Phase 1 Studies.
(academic.oup.com)
|
Carstens RP
…
Gillespie GL
Clinical Infectious Diseases
2026-05-20
|
#pharmacokinetics
#clinical trial
#hiv
#reverse transcriptase
|
|
0
|
|
Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compared with Adults Aged >/=60 Years.
(academic.oup.com)
|
Mitha E
…
Hulstrom V
Clinical Infectious Diseases
2026-05-20
|
#vaccination
#clinical trial
#immunogenicity
#safety
#rsv
|
|
0
|
|
Urgent versus early ERCP in mild-to-moderate acute cholangitis: a randomised controlled trial.
(gut.bmj.com)
|
Jagtap N
…
Reddy ND
Gut
2026-05-20
|
#infection
#clinical trial
#cholangitis
#ercp
|
|
0
|
|
Effects of Semaglutide on Cognitive Function in People With HIV: A Randomized, Controlled Trial.
(academic.oup.com)
|
Atieh O
…
McComsey GA
Clinical Infectious Diseases
2026-05-20
|
#inflammation
#cognition
#clinical trial
#hiv
#adiposity
|
|
0
|
|
Dolutegravir Reduces Human T-Cell Lymphotropic Virus Type 1 Proviral Load and Improves Neurological Outcomes in a Phase 2 Controlled Trial.
(academic.oup.com)
|
Brites C
…
Netto EM
Clinical Infectious Diseases
2026-05-20
|
#clinical trial
#antiviral
#virology
#neurological
#htlv-1
|